Prevalence and awareness of actinic keratosis: Barriers and opportunities - 09/12/12
Abstract |
Actinic keratoses (AKs) are common skin lesions that appear after long-term exposure to ultraviolet radiation. The presence of AKs is associated with an increased risk for development of nonmelanoma skin cancer. AKs vary widely in clinical and histologic presentation, which contributes to inadequate identification and presents challenges for consensus classification. Clinically adequate reduction in AK prevalence requires a multifaceted approach. There is a reasonable need to increase awareness and knowledge about AK, including symptoms, prevention, and associated risk of nonmelanoma skin cancer, especially among the public at large. Safe and effective treatment strategies are needed to optimize clearance of AKs, ideally to prevent progression to invasive cutaneous neoplasia.
Le texte complet de cet article est disponible en PDF.Key words : actinic keratosis, awareness, nonmelanoma skin cancer, prevalence, sun protection
Abbreviations used : AAD, ACS, AK, BCC, NMSC, PCP, SCC, UV
Plan
Publication of this article was supported by a grant from LEO Pharma Inc., Parsippany, NJ. |
|
Disclosure: Dr Rosen is a member of the speaker’s bureau for Graceway Pharmaceuticals and Medicis Pharmaceutical Corp, and is a consultant for LEO Pharma Inc. Dr Lebwohl is a consultant and an investigator for Graceway Pharmaceuticals and LEO Pharma Inc. |
|
Reprint requests: Panagiotis Zografos, LEO Pharma Inc., 1 Sylvan Way, Parsippany, NJ 07054. E-mail: panagiotis.zografos@leo-pharma.com. |
Vol 68 - N° 1S1
P. S2-S9 - janvier 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?